Pre-Open Stock Movers 01/05: (MYNZ) (WEJO) (YND) Higher; (ANNX) (GOCO) (SWIM) Lower (more...)

Pre-Open Stock Movers:

Mainz Biomed N.V. (NASDAQ: MYNZ) 72.9% HIGHER; entered into a Technology Rights Agreement with Socpra Sciences Santé Et Humaines S.E.C. (TTS) to access a portfolio of novel mRNA biomarkers for potential future integration into ColoAlert, the Companys highly efficacious, and easy-to-use detection test for colorectal cancer (CRC). Mainz is currently marketing ColoAlert in Europe through its unique business model of partnering with third-party laboratories for test kit processing versus the traditional methodology of operating a single facility. The Company is also preparing to initiate ColoAlerts regulatory pathway for approval in the United States.

Annexon, Inc. (Nasdaq: ANNX) 24.4% LOWER; announced interim data from its ongoing, open-label Phase 2 clinical trial of ANX005 in patients with Huntingtons disease (HD) who completed the 24-week treatment period. Annexon is developing ANX005, its lead monoclonal antibody candidate, for the treatment of a range of complement-mediated disorders, including HD.

Wejo Group Limited (NASDAQ: WEJO) 12.9% HIGHER; announced it is developing a breakthrough Wejo Neural EdgeTM platform that will enable intelligent handling of data from vehicles at scale, while providing incredible insights that protect privacy and empower automotive innovation. In partnership with Microsoft, Wejo will make the announcement virtually from the Microsoft Partners Pavilion at the Consumer Electronics Show in Las Vegas.

Oncternal Therapeutics, Inc. (Nasdaq: ONCT) 10.3% HIGHER; announced that following a successful End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) for zilovertamab, the companys investigational anti-ROR1 monoclonal antibody, the company and the FDA agreed on key elements of the companys potentially pivotal Phase 3 clinical trial of zilovertamab for the treatment of patients with relapsed or refractory mantle cell lymphoma (MCL). The FDA has also reviewed and agreed upon the key design features and operational details of the companys Phase 3 clinical trial protocol and Statistical Analysis Plan, which is being finalized based on the FDAs input.

GoHealth Inc. (NASDAQ: GOCO) 8.8% LOWER; BofA Securities downgraded from Buy to Underperform.

Latham Group, Inc. (Nasdaq: SWIM) 8% LOWER; commencement of a public offering of 12,000,000 shares of its common stock. Latham also intends to grant the underwriters a 30-day option to purchase up to an additional 1,800,000 shares of common stock.

Beyond Meat's (NASDAQ: BYND) 7.2% HIGHER; KFC restaurants nationwide will add Beyond Meat's (NASDAQ: BYND) meatless chicken to menus starting on Monday, according to a report from CNBC.

Inspire Medical Systems, Inc. (NYSE: INSP) 5.3% HIGHER; Revenue for the fourth quarter of 2021 is anticipated to be in the range of $78.0 million to $78.4 million, an approximately 70% increase over the same quarter last year

SMART Global Holdings, Inc. (NASDAQ: SGH) 5% LOWER; reported Q1 EPS of $2.16, $0.16 better than the analyst estimate of $2.00. Revenue for the quarter came in at $470 million versus the consensus estimate of $460.17 million. SMART Global Holdings, Inc. sees Q2 2022 EPS of $1.30-$1.60, versus the consensus of $1.36. SMART Global Holdings, Inc. sees Q2 2022 revenue of $415-455 million, versus the consensus of $426.2 million.

Roku Inc. (NASDAQ: ROKU) 4.9% LOWER; Atlantic Equities initiates coverage with an Underweight rating and a price target of $136.00.

Wayfair (NYSE: W) 4.3% LOWER; Wedbush downgraded from Outperform to Neutral with a price target of $160.00 (from $290.00).

salesforce.com (NYSE: CRM) 3.9% LOWER; UBS downgraded from Buy to Neutral with a price target of $265.00 (from $315.00).

LoanDepot Inc (NYSE: LDI) 3.6% HIGHER; Piper Sandler upgraded from Neutral to Overweight with a price target of $8.00 (from $9.00).

Alexandria Real Estate Equities, Inc. (NYSE: ARE) 3.5% LOWER; announced that it is commencing an underwritten public offering of 6,500,000 shares of the Company's common stock, subject to market conditions, in connection with the forward sale agreements described below.

Enerpac Tool Group (NYSE: EPAC) 3% LOWER; RBC Capital downgraded from Sector Perform to Underperform with a price target of $19.00 (from $20.00).

Adobe (NASDAQ: ADBE) 2.8% LOWER; UBS downgraded from Buy to Neutral with a price target of $575.00 (from $635.00).

Applied Therapeutics (NASDAQ: APLT) 2.6% HIGHER; Steven Cohen's Point72 Asset Management, L.P. disclosed a 9.8%, or 2,556,976 share, stake in the company.

Iris Energy Ltd. (NASDAQ: IREN) 2.5% HIGHER; Cowen initiates coverage with an Outperform rating and a price target of $31.00.

Stronghold Digital Mining Inc (NASDAQ: SDIG) 2% HIGHER; Cowen initiates coverage with an Outperform rating and a price target of $22.00.

3M (NYSE: MMM) 1% LOWER; RBC Capital downgraded from Sector Perform to Underperform with a price target of $166.00 (from $199.00).

Garmin Ltd. (NASDAQ: GRMN) 1% HIGHER; Deutsche Bank upgraded from Hold to Buy with a price target of $160.00 (from $148.00).

You May Also Be Interested In

• Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
• Midday movers: Netflix, Super Micro fall; Paramount Global gains
• Wells Fargo (WFC) drops as NII trails analyst estimates